In this episode - a busy week for the FDA, we talk about new approvals including: Nexletol, Nexlizet, Anjeso, Vyepti, Nurtec ODT, & Barhemsys. We also talk about an added indication for Nerlynx and give our regular update on flu season and the coronavirus. Don't forget to download, share, and subscribe! Enjoy!